Interval design to identify the optimal biological dose for immunotherapy

Area of Science:

• Oncology
• Immunology
• Biostatistics

Background:

• Immunotherapeutics are transforming cancer treatment, particularly for metastatic cancers.
• Checkpoint inhibition therapies show promise, but unique challenges exist compared to traditional cytotoxic agents.
• Limitations in current immunotherapy paradigms necessitate novel dose-finding strategies.

Purpose of the Study:

• To propose a desirability-based method for optimizing immunotherapeutic biological doses.
• To develop a novel dose allocation algorithm incorporating immune response alongside toxicity and tumor response.
• To evaluate the performance of the proposed design against existing dose-finding methods.

Main Methods:

• A desirability-based approach was developed to integrate toxicity, immune response, and tumor response data.
• A new dose allocation algorithm based on interval designs was proposed.
• Simulation studies were conducted to compare the proposed design with existing methods.

Main Results:

• The proposed desirability-based method effectively determines optimal biological doses for immunotherapeutics.
• The new dose allocation algorithm demonstrated desirable operating characteristics in simulations.
• The proposed design offers good performance and ease of implementation for dose-finding trials.

Conclusions:

• The developed desirability-based method and interval design algorithm offer a robust approach to immunotherapeutic dose optimization.
• This method addresses limitations in traditional dose-finding for immunotherapies by incorporating immune response.
• The findings support the use of this novel design in future clinical trials for enhanced cancer treatment.